Latest News and Press Releases

Zutphen, The Netherlands, 31 May 2017  As of today, EUR 940,000 out of the EUR 1.0 million tranche issued on March 8, 2017 have been converted into shares by European Select Growth Opportunities...

EBITDA improved compared to budget as a result of cost control Zutphen, the Netherlands - 31 May 2017 Market Update Q1 2017 The Q1 actual consolidated revenue of Esperite was higher compared to...

Zutphen, the Netherlands - 31 May 2017 The unfortunate liquidation procedure against Genoma SA, ruled on May 4th 2017, for which an appeal is still pending, has triggered the obligation to repay...

Zutphen, The Netherlands - 23 May 2017 Esperite N.V. (Euronext: ESP, "Esperite") announces that it has convened its Annual General Meeting of Shareholders ("AGM") to be held on 4 July 2017 at...

Zutphen, the Netherlands - 23 May 2017 ESPERITE N.V. (Euronext: ESP, "Esperite" or "the Group") has published today its Annual Report for the year ended 31 December 2016. The 2016 Annual Report...

Zutphen, The Netherlands - 20 May 2017 Esperite N.V. (Euronext: ESP, the "Company" or "Esperite") announces that additional time is needed for the Company to publish its Annual Report for the...

Genoma has filed appeal to the decision of liquidation taken on May 4th 2017. Genoma considers this decision arbitrary due to the circumstances of the commercial and legal relationship with...

Zutphen, les Pays-Bas, 15 mai 2017 La dernière action de Premaitha contre Genoma démontre sa tentative désespérée de cacher au public la situation financière de Premaitha. L'effet de leur action...

Zutphen, Paesi Bassi, 15 maggio 2017 Le ultime mosse di Premaitha contro Genoma, dimostrano il suo disperato tentativo di nascondere la situazione finanziaria di Premaitha stessa. L'effetto...

Zutphen, The Netherlands, 15 May 2017 Premaitha's latest action against Genoma demonstrates its desperate attempt to conceal Premaitha's financial situation. The effect of their legal action...